BPH Holmium Laser

Surgical excellence, redefined.

With more than 14 randomized controlled trials, spanning more than a decade, it is no surprise that the AUA and EAU both support HoLVP and HoLEP as a first line procedure for the treatment of BPH. Precise and controlled cutting and ablation allows the holmium laser energy to penetrate just enough to ablate tissue without the charring, deep thermal necrosis or collateral damage often seen with other laser treatments.

Explore Products

Proven Procedures For The Desired Clinical Outcome

HoLEP

Holmium Laser Enucleation of the Prostate
Proven effective for prostates of all sizes

Learn More

HoLVP

Holmium Laser Ablation of the Prostate
Proven effective for small to medium prostates

Learn More

“I have been researching MOSES for BPH and I have found significant improvement in procedure time and hemostasis time,
This clear, measurable clinical value translated into treating more patients each day in my practice and the team and I are grateful for that.
With this new technology we have been successful in transitioning the majority of our HoLEP procedures to same day discharge home.
I look forward to publishing these results soon.”

Dr. Amy E. Krambeck, Professor of Urology at Indiana University.

BPH with MOSES technology:

  • 15% faster enucleation
  • 40% faster hemostasis
  • 91% of patients discharged in less than 24 hours without a catheter
MOSES™ Technology

Want to learn more?

Get Clinical information, Procedure video’s,
detailed brochure and more..

Download MOSESTM info kit

Lumenis Urology Devices

MOSES PulseTM 120H

All-in-one urology platform for Vaporization, HoLEP, Flexible Ureteroscopic Lithotripsy and PCNL.

Lumenis® Pulse™30H

High Performance Fragmentation with User Experience in Mind.

Holmium Accessories

Performance, Durability
and Reliability

References

1. Krambeck et al. Comparative study of Holmium Laser Enucleation of the Prostate (HoLEP) with MOSES Enabled Pulsed Laser Modulation; Urology. 2019 Nov 29. pii: S0090-4295(19)31054-4. doi: 10.1016/j.urology.2019.11.029